MaddieBio's Solution

MaddieBio’s platform is being developed to leverage the power of advanced computational models with smart algorithms to simulate and knock down disease symptoms with existing approved drugs and generics and repurpose them for curing rare diseases starting with biomarkers tied to symptoms of Rett Syndrome.

Biomarker Integration and In–silico Simulation

By integrating biomarker data and conducting in–silico simulations, MaddieBio‘s platform provides valuable insights and accelerates the discovery of potential treatments for Rett Syndrome..

Biomarker Integration

  • Anonymized patient DNA data is collected and integrated into the platform.
  • The platform analyzes the genetic information to identify common biomarkers and genetic variations associated with Rett Syndrome.

Access to data with FDA approved drugs

  • MaddieBio‘s platform incorporates a comprehensive database of FDA–approved drugs.
  • The platform cross–references the genetic biomarkers with the drug database to identify potential matches.

In-silico Simulation

  • Once potential matches are identified, in–silico simulations are performed.
  • The simulations predict the efficacy of the drug candidates in treating Rett Syndrome and related symptoms.

Our Ideal Partners

Healthcare Providers

  • Doctors, genetics counselors, and other healthcare professionals can use our genetic testing and biomarker identification service to provide personalized treatment plans.

Research Institutions

  • MaddieBio collaborates with research institutes to advance genetic research and contribute to scientific discoveries in the field of personalized medicine.

Pharmaceutical and Therapeutic Companies

  • Pharmaceutical companies are interested in partnering to develop personalized medicine based on genetic data and biomarker identification
  • Targeting companies involved in drug discovery and repurposing drugs.

Partnerships with Leading Institutions

We welcome new organizations that want to partner with MaddieBio. Please contact us for more information on partnerships. 

CONTACT US

Building the Foundation

Affordable Whole Genome Sequencing (WGS) Testing

We empower individuals to unlock their genetic information through readily available and affordable WGS testing.

Unlocking the Potential with Gene & BioMarker Explorer

Genomic Variation Analysis

Uncover structural variations in the genome and gain insights into potential disease mechanisms and therapeutic targets.

Biomarker Identification

Identify and analyze biomarkers to accelerate the discovery and development of targeted therapies.

Partnership for Success

Partnership for Success: Targeted Therapeutics Collaboration

Our vast dataset allows us to pinpoint which genes and related cells map to the specific biomarker relevant.to your drug target. This empowers you to develop drugs or repurpose to address specific genetic variations and diseases, increasing the success rate of your treatment.